The Effect of BIA 9-1067 at Steady-state on the Levodopa Pharmacokinetics

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The purpose of this study is to determine the effect of repeated dosing of once-daily 25, 50 and 75 mg opicapone (OPC, development code BIA 9-1067) on the levodopa pharmacokinetics (PK), in comparison to placebo and 200 mg entacapone (ENT).
Epistemonikos ID: bdf92802ff93728786ec9c3ae609c0469354cd44
First added on: May 11, 2024